Kanizsai, A.; Molnar, T.; Varnai, R.; Zavori, L.; Tőkés-Füzesi, M.; Szalai, Z.; Berecz, J.; Csecsei, P.
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up. Vaccines 2022, 10, 447.
https://doi.org/10.3390/vaccines10030447
AMA Style
Kanizsai A, Molnar T, Varnai R, Zavori L, Tőkés-Füzesi M, Szalai Z, Berecz J, Csecsei P.
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up. Vaccines. 2022; 10(3):447.
https://doi.org/10.3390/vaccines10030447
Chicago/Turabian Style
Kanizsai, Andrea, Tihamer Molnar, Reka Varnai, Laszlo Zavori, Margit Tőkés-Füzesi, Zoltan Szalai, Janos Berecz, and Peter Csecsei.
2022. "Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up" Vaccines 10, no. 3: 447.
https://doi.org/10.3390/vaccines10030447
APA Style
Kanizsai, A., Molnar, T., Varnai, R., Zavori, L., Tőkés-Füzesi, M., Szalai, Z., Berecz, J., & Csecsei, P.
(2022). Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up. Vaccines, 10(3), 447.
https://doi.org/10.3390/vaccines10030447